HBM Healthcare Investments and Samsara BioCapital led a $36m series A financing round in Mineralys Therapeutics.

Synopsis

HBM Healthcare Investments and Samsara BioCapital, two venture capital firms, led a $36m series A financing round in Mineralys Therapeutics, an American biotech firm.

Principals

target

Mineralys Therapeutics

bidder

Hbm Healthcare Investments

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

jon congleton

CEO at MINERALYS THERAPEUTICS INC

Manager

target

Deals

£ 120 M

Total Value

cheston larson

Partner at Latham & Watkins

Lawyer

target

Deals

£ 19.53 B

Total Value

Bidder Team (2)

andreas wicki

CEO at HBM HEALTHCARE INVESTMENTS

Investor

bidder

Deals

£ 2.80 B

Total Value

srinivas akkaraju

CEO at SAMSARA BIOCAPITAL

Investor

bidder

Deals

£ 2.30 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy